{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T02:04:57Z","timestamp":1697508297413},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00105-019-4387-7","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T11:05:01Z","timestamp":1552907101000},"page":"265-270","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epidermolysis bullosa acquisita"],"prefix":"10.1007","volume":"70","author":[{"given":"S. C.","family":"Hofmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Weidinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"4387_CR1","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1097\/DAD.0000000000000829","volume":"39","author":"L Asfour","year":"2017","unstructured":"Asfour L, Chong H, Mee J et al (2017) Epidermolysis Bullosa Acquisita (Brunsting-Perry Pemphigoid variant) localized to the face and diagnosed with antigen identification using skin deficient in type VII collagen. Am J Dermatopathol 39:e90\u2013e96","journal-title":"Am J Dermatopathol"},{"key":"4387_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","volume":"131","author":"P Bernard","year":"1995","unstructured":"Bernard P, Vaillant L, Labeille B et\u00a0al (1995) Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 131:48\u201352","journal-title":"Arch Dermatol"},{"key":"4387_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2230.2010.03845.x","volume":"36","author":"L Delgado","year":"2011","unstructured":"Delgado L, Aoki V, Santi C et\u00a0al (2011) Clinical and immunopathological evaluation of epidermolysis bullosa acquisita. Clin Exp Dermatol 36:12\u201318","journal-title":"Clin Exp Dermatol"},{"key":"4387_CR4","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/exd.13446","volume":"26","author":"S Goletz","year":"2017","unstructured":"Goletz S, Zillikens D, Schmidt E (2017) Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases. Exp Dermatol 26:1154\u20131162","journal-title":"Exp Dermatol"},{"key":"4387_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00105-015-3723-9","volume":"67","author":"K Hoffmann","year":"2016","unstructured":"Hoffmann K, Hertl M, Sitaru C (2016) Molecular diagnosis of autoimmune dermatoses. Hautarzt 67:33\u201339","journal-title":"Hautarzt"},{"key":"4387_CR6","first-page":"1339","volume":"16","author":"SC Hofmann","year":"2018","unstructured":"Hofmann SC, Juratli HA, Eming R (2018) Bullous autoimmune dermatoses. J\u00a0Dtsch Dermatol Ges 16:1339\u20131358","journal-title":"J Dtsch Dermatol Ges"},{"key":"4387_CR7","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","volume":"136","author":"F Hubner","year":"2016","unstructured":"Hubner F, Recke A, Zillikens D et\u00a0al (2016) Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany. J\u00a0Invest Dermatol 136:2495\u20132498","journal-title":"J Invest Dermatol"},{"key":"4387_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.det.2011.06.020","volume":"29","author":"LR Intong","year":"2011","unstructured":"Intong LR, Murrell DF (2011) Management of epidermolysis bullosa acquisita. Dermatol Clin 29:643\u2013647","journal-title":"Dermatol Clin"},{"key":"4387_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13023-018-0896-1","volume":"13","author":"H Iwata","year":"2018","unstructured":"Iwata H, Vorobyev A, Koga H et al (2018) Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients. Orphanet J Rare Dis 13:153","journal-title":"Orphanet J Rare Dis"},{"key":"4387_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/JID.2015.356","volume":"136","author":"M Kasperkiewicz","year":"2016","unstructured":"Kasperkiewicz M, Sadik CD, Bieber K et\u00a0al (2016) Epidermolysis Bullosa Acquisita: from pathophysiology to novel therapeutic options. J\u00a0Invest Dermatol 136:24\u201333","journal-title":"J Invest Dermatol"},{"key":"4387_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004056","author":"G Kirtschig","year":"2003","unstructured":"Kirtschig G, Murrell D, Wojnarowska F et\u00a0al (2003) Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD004056","journal-title":"Cochrane Database Syst Rev"},{"key":"4387_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fmed.2018.00362","volume":"5","author":"H Koga","year":"2018","unstructured":"Koga H, Prost-Squarcioni C, Iwata H et al (2018) Epidermolysis Bullosa Acquisita: the 2019 update. Front Med 5:362","journal-title":"Front Med"},{"key":"4387_CR13","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.jaad.2011.12.032","volume":"68","author":"L Komorowski","year":"2013","unstructured":"Komorowski L, Muller R, Vorobyev A et\u00a0al (2013) Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. J\u00a0Am Acad Dermatol 68:e89\u2013e95","journal-title":"J Am Acad Dermatol"},{"key":"4387_CR14","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/exd.13335","volume":"26","author":"RJ Ludwig","year":"2017","unstructured":"Ludwig RJ (2017) Signalling and targeted therapy of inflammatory cells in epidermolysis bullosa acquisita. Exp Dermatol 26:1179\u20131186","journal-title":"Exp Dermatol"},{"key":"4387_CR15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1001\/archderm.135.8.954","volume":"135","author":"MC Luke","year":"1999","unstructured":"Luke MC, Darling TN, Hsu R et\u00a0al (1999) Mucosal morbidity in patients with epidermolysis bullosa acquisita. Arch Dermatol 135:954\u2013959","journal-title":"Arch Dermatol"},{"key":"4387_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jaad.2017.11.029","volume":"78","author":"JM Meijer","year":"2018","unstructured":"Meijer JM, Atefi I, Diercks GFH et\u00a0al (2018) Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases. J\u00a0Am Acad Dermatol 78:754\u2013759.e6","journal-title":"J Am Acad Dermatol"},{"key":"4387_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/bjd.16138","volume":"179","author":"C Prost-Squarcioni","year":"2018","unstructured":"Prost-Squarcioni C, Caux F, Schmidt E et al (2018) International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita. Br J Dermatol 179:30\u201341","journal-title":"Br J Dermatol"},{"key":"4387_CR18","first-page":"399","volume":"108","author":"E Schmidt","year":"2011","unstructured":"Schmidt E, Zillikens D (2011) The diagnosis and treatment of autoimmune blistering skin diseases. Dtsch Arztebl Int 108:399\u2013405","journal-title":"Dtsch Arztebl Int"},{"key":"4387_CR19","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1111\/bjd.15800","volume":"177","author":"T Schmidt","year":"2017","unstructured":"Schmidt T, Hoch M, Lotfi Jad SS et\u00a0al (2017) Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a\u00a0multicentre analysis. Br J Dermatol 177:1683\u20131692","journal-title":"Br J Dermatol"},{"key":"4387_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.det.2011.11.008","volume":"30","author":"DF Sebaratnam","year":"2012","unstructured":"Sebaratnam DF, Frew JW, Davatchi F et al (2012) Quality-of-life measurement in blistering diseases. Dermatol Clin 30:301\u2013307","journal-title":"Dermatol Clin"},{"key":"4387_CR21","first-page":"1077","volume":"16","author":"N Beek Van","year":"2018","unstructured":"Van Beek N, Zillikens D, Schmidt E (2018) Diagnostik blasenbildender Autoimmundermatosen. J\u00a0Dtsch Dermatol Ges 16:1077\u20131092","journal-title":"J Dtsch Dermatol Ges"},{"key":"4387_CR22","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1067\/mjd.2002.125079","volume":"47","author":"RM Vodegel","year":"2002","unstructured":"Vodegel RM, De Jong MC, Pas HH et al (2002) IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. J\u00a0Am Acad Dermatol 47:919\u2013925","journal-title":"J Am Acad Dermatol"},{"key":"4387_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/1744666X.2016.1221343","volume":"13","author":"A Vorobyev","year":"2017","unstructured":"Vorobyev A, Ludwig RJ, Schmidt E (2017) Clinical features and diagnosis of epidermolysis bullosa acquisita. Expert Rev Clin Immunol 13:157\u2013169","journal-title":"Expert Rev Clin Immunol"},{"key":"4387_CR24","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1038\/jid.2011.231","volume":"131","author":"C Zumelzu","year":"2011","unstructured":"Zumelzu C, Le Roux-Villet C, Loiseau P et al (2011) Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita. J\u00a0Invest Dermatol 131:2386\u20132393","journal-title":"J Invest Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-019-4387-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-019-4387-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-019-4387-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:22:06Z","timestamp":1584404526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-019-4387-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4387"],"URL":"https:\/\/doi.org\/10.1007\/s00105-019-4387-7","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"18 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.C.\u00a0Hofmann und A.\u00a0Weidinger geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}